LebwohlM., SiskinS.B., EpinetteW., BrenemanD., FunicellaT., KalbR., MooreJ.A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol.1996; 35: 268–269.
2.
KaufmannR., BibbyA.J., BissonnetteR., CambazardF., ChuA.C., DecroixJ., DouglasW.S., LowsonD., MascaroJ.M., MurphyG.M., StymneB.A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris. Dermatology.2002; 205(4): 389–93.
3.
OrtonneJ.P., KaufmannR., LechaM., GoodfieldM.Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial. Dermatology.2004; 209(4): 308–13.
4.
Van de KerkhofP.C., WaselN., KragballeK., CambazardF.A two-compound product containing calcipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severity. Dermatology.2005; 210(4): 294–9.
5.
TraulsenJ.Bioavailability of betamethasone dipropionate when combined with calcipotriol. Int J Dermatol.2004; 43(8): 611–7.
6.
Van de KerkhofP.C.The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial. Br J Dermatol.2004; 151(3): 663–8.
7.
KragballeK., NoerrelundK.L., LuiH., OrtonneJ.P., WozelG., UurasmaaT., FlemingC., EstebaranzJ.L., HanssenL.I., PerssonL.M.Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Br J Dermatol.2004; 150(6): 1167–73.
